McDonough, Rosalie
Elsayed, Sarah
Meyer, Lukas
Ewers, Theresa
Bechstein, Matthias
Kniep, Helge
Nawka, Marie Teresa
Faizy, Tobias D.
Schön, Gerhard
Thomalla, Götz
Fiehler, Jens
Hanning, Uta
Kemmling, Andre
Broocks, Gabriel
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 24 October 2021
Accepted: 25 August 2022
First Online: 29 November 2022
Competing interests
: Jens Fiehler: Consultant for Acandis, Boehringer Ingelheim, Codman, Microvention, Sequent, Stryker. Speaker for Bayer Healthcare, Bracco, Covidien/ev3, Penumbra, Philips, Siemens. Grants from Bundesministerium für Wirtschaft und Energie (BMWi), Bundesministerium für Bildung und Forschung (BMBF), Deutsche Forschungsgemeinschaft (DFG), European Union (EU), Covidien, Stryker (THRILL study), Microvention (ERASER study), Philips. Götz Thomalla: Has received grant support and lecture fees from Bayer, personal fees from Acandis, Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, and Daiichi Sankyo, Portola, and Stryker. Andre Kemmling: Research collaboration agreement: Siemens Healthcare. All other authors declare that they have no conflicts of interest.